new antipsychotics on the Canadian market

You'll see new antipsychotics on the Canadian market.

Invega (paliperidone) is an atypical antipsychotic for schizophrenia. It's the active metabolite of risperidone (Risperdal).

Invega is dosed once daily, and does NOT require initial dose titration like risperidone. It also doesn't have as many drug interactions because it's not extensively metabolized by the liver.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote